1 / 46

Vasculitis

Vasculitis. Joanna Zalewska. Definition. Group of a rare conditions characterized by inflammation of blood vessels. Classification. Epidemiology. Diseases of the extremes age Kawasaki diseases and Henoch- Schoenlein purpura occur in childhood, whilst GCA occurs in those aged >65 years

libitha
Télécharger la présentation

Vasculitis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Vasculitis Joanna Zalewska

  2. Definition • Group of a rare conditions characterized by inflammation of blood vessels

  3. Classification

  4. Epidemiology • Diseases of the extremes age • Kawasaki diseases and Henoch- Schoenlein purpura occur in childhood, whilst GCA occurs in those aged >65 years • The other types are much rare, but also tend to occur in older people

  5. Clinical features • In the early stages- the symptoms can be non-specific • The age is important (Takayasu, GCA) • Systemic- fever, weight loss, myalgia, arthralgia • ENT- epistaxis, nasal crusting, deaffness, sinusitis • Pulmonary- cough, haemoptysis, dyspnoea, wheeze • Late onset asthma- CSS • Cutaneous- purpuric rash, ulcers

  6. Neurological- peripheral neuropathy, headache- especially located in the temple, new onset or of a different character to previous haedache • Vascular- jaw claudication, limb claudication, carotidynia, difficulty in obtaining blood pressure readings

  7. Key featues on examination • Cutaneous- purpuric rash, ulcers, digital gangrene • Musculoskeletal- synovitis • Neurological- motor or sensory neuropathy, mononeuritis multiplex • Vascular- tender non-pulstile temporal arteries, absent peripheral pulses, bruits, difficulty in obtaining BP measurement • ENT- nasal bridge collapse

  8. General investigations • FBC anaemia, leucocytosis, eosinophilia • Acute phase response (ESR and CRP) • Liver function

  9. Assessment of organ involvement • Urinalysis (proteinuria, haematuria, red cell casts) • Renal function (creatinine clearance, quantification of protein leak if present using either 24-h protein excretion or urine/ creatinine ratio) • CXR- infiltrates, haemorrhage, granuloma • Liver function • Nervous system • Cardiac function (ECG, echocardioography) • Gut (celiac axis angiography)

  10. Serological investigations • cANCA- strongly associated with WG (>90%) • pANCA- MPA and CSS • ANA • RF- may be positive in cryoglobulinaemic vasculitis or systemic rheumatoid vasculitis • Anticardiolipin antibodies • Complement (low in cryoglobulinaemic vasculitis) • Cryoglobulins

  11. Giant cell arteritis (GCA) • The most common of systemic vasculititides and is characterized by envolvement of large vessels particularly the extra cranial branches of the aorta • Often involves temporal artery, aorta and its major branches • Patients older than 50

  12. ACR criteria of GCA (>3 criteria) • Age onste >50 years • New headache • Temporal artery abnormality (tenderness to plaplation or decreased pulsation) • Increase in ESR > 50 mm/h • Abnormal artery biopsy- predominance of mononuclear infiltration or granulomatous inflammation

  13. Clinical features • In early stages the symptoms are non-specific (fever, weight loss, myalgia, morning stiffness) • Headache • Visual disturbance- suddenly, without warning and may be bilateral, transient visual loss • Jaw claudication- pain on eating • Arm or leg claudication

  14. Examination • The temporal arteries- tender, thickened and non pulsatile • Eye- ischaemic optic neuropathy

  15. Investigations • FBC anaemia, thrombocytosis • Acute phase response (ESR and CRP) • Temporal artery biopsy- as soon as possible • Ultrasonography • Angiography

  16. Prognosis • Blindness risk (reduced by early corticosteroids therapy) Treatment • High dose of corticosteroids starting 0.7- 1 mg/kg (60- 80 mg) oral • Methylprednisolone (15 mg/kg) for 3 days – 1 g per day • Low dose of aspirin- reduces the risk of thrombosis • Azathioprine or methotrexate

  17. Takayasu arteritis • Rare systemic, vasculitis of unknown aetiology, characterized by large vessel vasculitis • Granulomatous inflammation of the aorta and its major branches • Patients younger than 50

  18. Criteria >3 • Age <40 years old • Claudication of extremities- development and worsening of fatigue and discomfort in muscles of one or more extermity while in use, espacially the upper extremities • Decreased brachial arterialpulse • BP difference >10 mmHg in systolic BP between arms • Bruit over subclavian arteries or aorta • Arteriogram abnormality- narrowing or occlusion

  19. Occurence of stroke in a young person especcially when associated with a high ESR or CRP • Fever, weight loss, myalgia, arthralgia • Absence or asymmetry of peripheral pulses • Claudication of arms or legs • TIA and stroke

  20. Examination • BP inequality between arms and legs • Hypertension new onset or evidence of renal artery stenosis • Vascular bruits most often heard over the carotid artries • Carotidynia • Neurological symptoms

  21. FBC anaemia • ESR and CRP elevation • Angiography- gold standard- localized narrowing or irregularity of the lumen, stenosis and aneurysms • MR- angiography • PET • High resolution Doppler ultrasound • ANCA, ANA, RF, anticardiolipin antibodies- negative

  22. Remisson can be achieved in the majority of patients using corticosteroids, but 73% of patients required additional immunosuppressants

  23. Oral corticosteroids start at 1 mg/kg (maximum dose 60- 80 mg) and taper quickly; aim for 10 mg/day at 6 months • Immunosuppression with methotrexate or azthioprine should be started at the same time as oral corticosteroids • Control hypertension • Surgery- bypass procedure or stenting

  24. Wegener’s granulomatosis • Rare systemic vasculitis of unknown aetiology, characterized by involvement of the upper airways with granuloma formation • Granulomatous inflammation involving the respiratory tract and necrotizing vasculitis affectin small to medium sized vessels

  25. Criteria >2 • Nasal or oral inflammation- oral ulcers or purulent/ bloody nasal discharge • Abnormal chest radiograph- nodules, fixed infiltrates or cavities • Urinary sediment- microhaematuria (>5 red cells per high power field) or red cell casts in urinary sediment • Granulomatous inflammation- histological changes showing granulomatous on biopsy inflammation within the wall artery or in the perivascular or extravascular area

  26. Clinical features • Systemic- fever, weight loss, myalgia, arthralgia • ENT- epistaxis, nasal crusting, deaffness, sinusitis • Pilmonary- cough, haemoptysis, dyspnoea • Cutaneous- purpuric rash, ulcers • Peripheral neuropathy

  27. Skin- purpura, ulcers • Arthritis • Eye- scleritis, proptosis- retroorbital mass • ENT- nasal collapse, destructive sino-nasal disease

  28. Anaemia, leucocytosis, eosinophilia • ESR and CRP- elevation • Liver function • Urinalysis (proteinuria, haematuria, red cell casts) • Renal function (creatinine clearance, quantification of protein leak if present using either 24-h protein excretion or urine protein/creatinine ratio) • CXR- infiltrates, haemorrhage, granuloma • Nervous system- nerve conduction • Cardiac function- ECG, echocardiography • Skin- biopsy

  29. cANCA- strongly associated with WG >90% • ANA, RF, anticardiolipin antibodies, complement • cryoglobulins

  30. Differential diagnosis • Other types of vasculitis • Vasculitis mimics- malignancy, atrial myxoma, calciphylaxis • Infection • Blood cultures • Viral serology (HBV, HCV, HIV, CMV) • Echocardiography

  31. Churg- Strauss Syndrome • Eosinophil- rich and granulomatous inflammation involving the respiratory tract and necrotizing vasculitis affecting small to medium- sized vessels associated with asthma and eosinophilia • Male • Peak age onset- 65- 74 years • Aetiology is unknown- leukotriene inhibitors

  32. ACR Criteria >4 • Asthma- history of wheezing or diffuse high pitch rales on expiration • Eosinophilia>10 % on white cell differential count • Mononeuropathy or polyneuropathy- development of mononeuropathy, multiple menoneuropathies or polyneuropathy • Pulmonary infiltrates • Paranasal sinus abnormality- history of acute or chronic paranasolor tenderness • Extravascular eosinophilis- biopsy including artery

  33. Key points on history • Adult onset asthma- difficult to control • Systemic symptoms • Pulmonary- cough, wheeze, dyspnoea, upper respiratory tract symptoms • Cutaneous- purpuric rash or cutaneous granulomata occur in up to 50% • Neurological- peripheral neuropathy or mononeuritis multiplex • Cardiac- dyspnoea, cardiac failure, arrythmia

  34. Key points on examination • Skin- purpuric vasculitic rash or palpable granulomata • Musculoskeletal- arthritis • Ophtalmic- scleritis • ENT- nasal polyps • Neurological- mononeuritis multiplex, sensory or motor neuropathy

  35. Anaemia, leucocytosis, eosinophilia >1.5 x109 • ESR and CRP- elevation • Liver function • ANCA- 50% of patients are ANCA positive

  36. Assessment of organ involvement • Urinalysis (proteinuria, haematuria, red cell casts) • Renal function (creatinine clearance, quantification of protein leak, 24-h protein excretion or urine protein/ creatinine ratio) • CXR- infiltrates, haemorrhage, granuloma • Liver function • Nervous system • Cardiac function • Skin- biopsy

  37. Differential diagnosis • Other causes of hypereosinophilia- hypereosinophilic syndrome, eosinophilic leukaemia, chronic parasitic infection

  38. Treatment • Induction, consolidation, maintenance of remission • immunosuppression

  39. Microscopic polyangiitis • Necrotizing vasculitis, with few or no immune deposits affecting small vessels

  40. Key features on history • Systemic- fever, weight loss, myalgia, arthralgia • Pulmonary- cough, haemoptysis, dyspnoea • Renal involvement • Cutaneous- purpuric rash • Neurological- peripheral neuropathy

  41. Key features on examination • Cutaneous- purpuric rash, digital ischaemia, ulcers, livedo reticularis • Neurological- mononeuritis multiplex • Pulmonary- intersitial lung disease

  42. Assessment of organ involvement • Urinalysis (proteinuria, haematuria, red cell casts) • Renal function (creatinine clearance, quantification of protein leak, 24-h protein excretion or urine protein/ creatinine ratio) • CXR- infiltrates, haemorrhage, granuloma • Liver function • Nervous system • Cardiac function • Skin- biopsy

  43. Five factor score • Proteinuria >1g/ 24h • Serum creatinine> 140 umol/l • Gastrointestinal involvement • Cardiomyopathy • CNS involvement

  44. Treatment- vasculitis • Induction- oral corticosteroids combined with methotrexate, mycophenolate mofetil or cyclophosphamide • Prophylaxis against pneumocystis carinii, PPI against gastric ulceration, Mesna against haemorrhagic cystitis, prophylaxis against osteoporosis • Plasma exchange • Azathioprine

  45. Polyarteritis nodosa • Necrotizing inflammation of medium- sized or small arteries without glomerulonephritis or vasculitis in capillaries or venules

  46. Criteria • Weight loss • Livedo reticularis • Testicular pain or tenderness • Myalgias, weakness or leg tenderness • Mononeuropathy or polyneuropathy • Diastolic BP>90 mmHg • Elevated blood urea or creatinine • Hepatitis B virus • Arteriographic abnormality • Biopsy of small or medium vessel

More Related